Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation. [PDF]
Wisborg FD+11 more
europepmc +1 more source
The inhibition of high and low molecular weight urokinase in plasma [PDF]
G Murano, D Aronson, L Williams, L Brown
openalex +1 more source
Plasminogen Activator (PA) Activity Of Urokinase (UK) , The Vascular Plasminogen Activator (VPA) , Plasma Kallikrein (PK) , And Hageman Factor (HF) In The Presence And Absence Of Fibrin [PDF]
Bernd R. Binder, R Beckmann, M. E. Jorg
openalex +1 more source
Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients. [PDF]
Ma T, Li C, Song G, Yao S.
europepmc +1 more source
Chest drainage or repeated thoracentesis for pleural infections: a clinical dilemma. [PDF]
Salerni C, Mondoni M, Sotgiu G.
europepmc +1 more source
Serum Soluble Urokinase-Type Plasminogen Activator Receptor: A Promising Biomarker for Stable Chronic Obstructive Pulmonary Disease Patients. [PDF]
D R, Johnson P, Das S, Gr S.
europepmc +1 more source
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro. [PDF]
Peter G. Gibson+3 more
openalex +1 more source